Purpose: The purpose of this study was to report the efficiency and safety of intravitreal aflibercept for the treatment of cystoid macular edema (CME) secondary to central retinal vein occlusion (CRVO).
Methods: This is a retrospective cohort study. Ten naive eyes of ten patients with CME secondary to CRVO were included.